Literature DB >> 11276104

Biodistribution of ultrasmall iron oxide particles in the rat liver.

B E Van Beers1, C Sempoux, R Materne, M Delos, A M Smith.   

Abstract

Ferumoxtran, an ultrasmall superparamagnetic iron oxide particle, can be located in several tissue compartments in the liver, namely the extracellular space (blood and interstitium), reticuloendothelial cells, and possibly hepatocytes. To better understand the compartmental distribution of ferumoxtran in the liver, we performed a longitudinal study in the rat using microscopy and magnetic resonance imaging. At light microscopy, no substantial cellular uptake of ferumoxtran was observed before one hour after injection. With a dose of 15 micromol Fe/kg, the number of ferumoxtran particles in the reticuloendothelial cells peaked between one and four hours and with a 150 micromol Fe/kg dose, it peaked between eight and 24 hours. Within hepatocytes, only sparse particles were observed with electron microscopy, at a dose of 150 micromol Fe/kg. Imaging performed up until one hour after ferumoxtran injection showed a significant increase in liver signal intensity on T1-weighted images. These results suggest that ferumoxtran mainly acts as an extracellular agent for at least one hour in the rat and that reticuloendothelial accumulation peaks at later time points. Substantial uptake within hepatocytes did not occur.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11276104     DOI: 10.1002/jmri.1083

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  10 in total

1.  Molecular immunolabeling with recombinant single-chain variable fragment (scFv) antibodies designed with metal-binding domains.

Authors:  Marek Malecki; Annie Hsu; Lynn Truong; Sylvia Sanchez
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

2.  In vitro studies on ultrasmall superparamagnetic iron oxide nanoparticles coated with gummic acid for T2 MRI contrast agent.

Authors:  I Rabias; H Pratsinis; G Drossopoulou; M Fardis; T Maris; N Boukos; N Tsotakos; D Kletsas; E Tsilibary; G Papavassiliou
Journal:  Biomicrofluidics       Date:  2007-11-30       Impact factor: 2.800

Review 3.  In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles.

Authors:  Hamed Arami; Amit Khandhar; Denny Liggitt; Kannan M Krishnan
Journal:  Chem Soc Rev       Date:  2015-09-21       Impact factor: 54.564

4.  Measurements of T1 and T2 relaxation times of colon cancer metastases in rat liver at 7 T.

Authors:  G Gambarota; A Veltien; H van Laarhoven; M Philippens; A Jonker; O R Mook; W M Frederiks; A Heerschap
Journal:  MAGMA       Date:  2004-12-01       Impact factor: 2.310

5.  Administration Routes as Modulators of the Intrahepatic Distribution and Anti-Anemic Activity of Salicylic Acid/Fe3O4 Nanoparticles.

Authors:  Bogdan Mîndrilă; Sandra-Alice Buteică; Ion Mîndrilă; Dan-Eduard Mihaiescu; Marina-Daniela Mănescu; Ion Rogoveanu
Journal:  Biomedicines       Date:  2022-05-23

6.  Toxicity and Biodistribution of Activated and Non-activated Intravenous Iron Oxide Nanoparticles.

Authors:  Ja Tate; Ja Ogden; Rr Strawbridge; Ze Pierce; Pj Hoopes
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2009-02-12

7.  Cytotoxicity evaluation of carbon-encapsulated iron nanoparticles in melanoma cells and dermal fibroblasts.

Authors:  Ireneusz P Grudzinski; Michal Bystrzejewski; Monika A Cywinska; Anita Kosmider; Magdalena Poplawska; Andrzej Cieszanowski; Agnieszka Ostrowska
Journal:  J Nanopart Res       Date:  2013-07-24       Impact factor: 2.253

8.  Ferumoxytol-enhanced magnetic resonance imaging assessing inflammation after myocardial infarction.

Authors:  Colin G Stirrat; Shirjel R Alam; Thomas J MacGillivray; Calum D Gray; Marc R Dweck; Jennifer Raftis; William Sa Jenkins; William A Wallace; Renzo Pessotto; Kelvin Hh Lim; Saeed Mirsadraee; Peter A Henriksen; Scott Ik Semple; David E Newby
Journal:  Heart       Date:  2017-06-22       Impact factor: 5.994

9.  Targeting HER2-breast tumors with scFv-decorated bimodal nanoprobes.

Authors:  Christophe Alric; Katel Hervé-Aubert; Nicolas Aubrey; Souad Melouk; Laurie Lajoie; William Même; Sandra Même; Yann Courbebaisse; Anastasia A Ignatova; Alexey V Feofanov; Igor Chourpa; Emilie Allard-Vannier
Journal:  J Nanobiotechnology       Date:  2018-02-21       Impact factor: 10.435

10.  A noninvasive method to determine the fate of Fe(3)O(4) nanoparticles following intravenous injection using scanning SQUID biosusceptometry.

Authors:  Wei-Kung Tseng; Jen-Jie Chieh; Yi-Fan Yang; Chih-Kang Chiang; Yuh-Lien Chen; Shieh Yueh Yang; Herng-Er Horng; Hong-Chang Yang; Chau-Chung Wu
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.